Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000030

Sr. VP & General Counsel acquired 2,519 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gardiner Nathaniel S. · Sr. VP & General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-06 Exercise or conversion : show line 1 in the form +1,724 $34.70 $59,823 25,702 D
2019-03-06 Exercise or conversion : show line 2 in the form +795 $31.42 $24,979 26,497 D

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-03-06 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −1,724 $34.70 2024-05-09 1,724 70,976 D
2019-03-06 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −795 $31.42 2025-11-20 795 24,705 D
Loading xslF345X03/edgar.xml…